share_log
Breakings ·  Oct 7 19:00
Brainstorm Cell Therapeutics to Provide Corporate Update on Phase 3B Nurown® Trial at the 2024 Maxim Healthcare Virtual Summit
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment